deltatrials
No Longer Available EXPANDED_ACCESS NCT03592576

Expanded Access to Navitoclax

Sponsor: AbbVie

Conditions Acute Lymphocytic Leukemia (ALL) Lymphoblastic Lymphoma Myelofibrosis
Interventions Navitoclax Venetoclax
Updated 15 times since 2018 Last updated: May 3, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Acute Lymphocytic Leukemia (ALL) and Lymphoblastic Lymphoma, this trial is ongoing. The trial is conducted by AbbVie and has accumulated 15 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2018 – ~Apr 2019 · 8 months · monthly snapshot~Apr 2019 – ~Feb 2020 · 10 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Nov 2020 · 7 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Jun 2021 · 4 months · monthly snapshot~Jun 2021 – ~Sep 2022 · 15 months · monthly snapshot~Sep 2022 – ~Feb 2023 · 5 months · monthly snapshot~Feb 2023 – ~Feb 2024 · 12 months · monthly snapshot~Feb 2024 – ~May 2024 · 3 months · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    No Longer Available

  2. Jul 2024 — Sep 2024 [monthly]

    No Longer Available

  3. Jun 2024 — Jul 2024 [monthly]

    No Longer Available

    Status: Available → No Longer Available

  4. May 2024 — Jun 2024 [monthly]

    Available

  5. Feb 2024 — May 2024 [monthly]

    Available

▶ Show 10 earlier versions

  1. Feb 2023 — Feb 2024 [monthly]

    Available

  2. Sep 2022 — Feb 2023 [monthly]

    Available

  3. Jun 2021 — Sep 2022 [monthly]

    Available

  4. Feb 2021 — Jun 2021 [monthly]

    Available

  5. Jan 2021 — Feb 2021 [monthly]

    Available

  6. Nov 2020 — Jan 2021 [monthly]

    Available

  7. Apr 2020 — Nov 2020 [monthly]

    Available

  8. Feb 2020 — Apr 2020 [monthly]

    Available

  9. Apr 2019 — Feb 2020 [monthly]

    Available

  10. Aug 2018 — Apr 2019 [monthly]

    Available

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AbbVie
Data source: AbbVie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.